SALMET-VEC Trademark

Trademark Overview


On Monday, November 18, 2019, a trademark application was filed for SALMET-VEC with the United States Patent and Trademark Office. The USPTO has given the SALMET-VEC trademark a serial number of 88697201. The federal status of this trademark filing is REGISTERED as of Tuesday, July 20, 2021. This trademark is owned by Guangzhou Sinogen Pharmaceutical Co., Ltd.. The SALMET-VEC trademark is filed in the Pharmaceutical Products category with the following description:

Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Protein arrays for diagnosing cancer; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Tumor suppressing agents; all containing in whole or significant part, gene therapy substances
salmet-vec

General Information


Serial Number88697201
Word MarkSALMET-VEC
Filing DateMonday, November 18, 2019
Status700 - REGISTERED
Status DateTuesday, July 20, 2021
Registration Number6429132
Registration DateTuesday, July 20, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 12, 2020

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the stylized wording "SALMET-VEC" above which are four Chinese characters.
Goods and ServicesAnti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Protein arrays for diagnosing cancer; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Tumor suppressing agents; all containing in whole or significant part, gene therapy substances
Transliteration StatementThe non-Latin characters in the mark transliterate to "SALMET-VEC" and this has no meaning in a foreign language.
Translation of Words in MarkThe wording "SALMET-VEC" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 25, 2019
Primary Code005
First Use Anywhere DateThursday, November 12, 2020
First Use In Commerce DateThursday, November 12, 2020

Trademark Owner History


Party NameGuangzhou Sinogen Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressGuangzhou 510006
CN

Party NameGuangzhou Sinogen Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGuangzhou 510006
CN

Party NameGuangzhou Sinogen Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGuangzhou 510006
CN

Trademark Events


Event DateEvent Description
Tuesday, December 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 20, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 15, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, June 14, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 11, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 11, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 2, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 2, 2021NON-FINAL ACTION E-MAILED
Tuesday, March 2, 2021SU - NON-FINAL ACTION - WRITTEN
Tuesday, January 26, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 6, 2021USE AMENDMENT FILED
Tuesday, January 26, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 6, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, July 7, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 12, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 12, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 3, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 1, 2020ASSIGNED TO LIE
Wednesday, March 25, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, February 22, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, February 22, 2020NON-FINAL ACTION E-MAILED
Saturday, February 22, 2020NON-FINAL ACTION WRITTEN
Thursday, February 20, 2020ASSIGNED TO EXAMINER
Tuesday, November 26, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, November 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 21, 2019NEW APPLICATION ENTERED IN TRAM